TheraRadar
← Back
Data updated: Jun 28, 2026

EPIC PHARMA LLC

Generics

EPIC PHARMA LLC is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Gastroenterology. Key products include LAMIVUDINE AND ZIDOVUDINE.

1952
Since
169
Drugs
-
Trials
1
New Drugs (2yr)
Modality:
1 Small Molecules

EPIC PHARMA LLC's Key Drugs

EPIC PHARMA LLC's core commercial portfolio centers on OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, BUCAPSOL, KLAYESTA, spanning Cardiovascular and Infectious Disease — its most strategically important drugs approved in the last 15 years.

EPIC PHARMA LLC's Therapeutic Areas

EPIC PHARMA LLC's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Infectious Disease, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Cardiovascular 33%
13 drugs
Infectious Disease 21%
8 drugs
Gastroenterology 15%
6 drugs
Dermatology 15%
6 drugs
Neurology 15%
6 drugs

EPIC PHARMA LLC Pipeline Snapshot

Active clinical trials for EPIC PHARMA LLC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • OLANZAPINE AND FLUOXETINE HYDROCHLORIDE leads revenue
  • 3 key drugs tracked

Trial Catalysts

  • Cardiovascular pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling